Of 1,805 genes (across the 46 CD4+ T cell gene expression profiles), expression of 61 genes had evidence (FDR-P < 0.05) for a potential causal effect on CRC risk (Fig. 3; Table S2). This evidence concerns the gene CD4 and colorectal carcinoma.